+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07874308

Real-World Study of HR20013 Intravenous Infusion for Preventing Chemotherapy-Induced Nausea and Vomiting in Cancer Patients

Led by Sun Yat-sen University · Updated on 2026-10-14

3000

Participants Needed

1

Research Sites

43 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying HR20013, a newly approved medicine in China, to prevent nausea and vomiting caused by cancer treatment. This real-world, observational study involves about 3,000 patients with cancer receiving HR20013 as part of their routine care at over 30 hospitals. The study includes a subgroup of 100 patients with mild to moderate liver impairment to better understand the medicines use in different patient groups. Participants receive HR20013 through an intravenous infusion before their anticancer therapy. The study observes patients receiving either HR20013 alone or in combination with other treatments, following usual clinical care without additional study-mandated interventions. Two groups are included patients with mild to moderate liver impairment and those without liver impairment. Both groups are monitored to evaluate how well HR20013 prevents nausea and vomiting during acute, delayed, and overall phases after chemotherapy. Throughout the study, patients report episodes of nausea and vomiting using standard criteria, and researchers assess adverse drug reactions. Quality of life is measured using a specific questionnaire related to emesis. Data collection follows routine clinical visits and practices, tracking safety and effectiveness over each treatment cycle lasting 21 days, continuing for up to 30 days after the last HR20013 dose. The study aims to guide better clinical use of HR20013 for preventing chemotherapy-induced nausea and vomiting.

CONDITIONS

Brief Title

HR20013 for the Prevention of Nausea and Vomiting in Patients With Cancer: A Real-World Study

Research Team

L

Li Zhang, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here